Muscle histology vs MRI in Duchenne muscular dystrophy.
OBJECTIVE
There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation.


METHODS
We studied the degree of muscle involvement in the lower leg muscles of 34 patients with DMD >8 years, using muscle MRI. In a subgroup of 15 patients we correlated the muscle MRI findings with the histology of open extensor digitorum brevis (EDB) muscle biopsies. Muscle MRI involvement was assigned using a scale 0-4 (normal-severe).


RESULTS
In all patients we documented a gradient of involvement of the lower leg muscles: the posterior compartment (gastrocnemius > soleus) was most severely affected; the anterior compartment (tibialis anterior/posterior, popliteus, extensor digitorum longus) least affected. Muscle MRI showed EDB involvement that correlated with the patient's age (p = 0.055). We show a correlation between the MRI and EDB histopathologic changes, with MRI 3-4 grades associated with a more severe fibro-adipose tissue replacement. The EDB was sufficiently preserved for bulk and signal intensity in 18/22 wheelchair users aged 10-16.6 years.


CONCLUSIONS
This study provides a detailed correlation between muscle histology and MRI changes in DMD and demonstrates the value of this imaging technique as a reliable tool for the selection of muscles in patients recruited into clinical trials.
The Dubowitz Neuromuscular Centre, Institute of Child Health, London, UK.
M
M
Kinali
V
V
Arechavala-Gomeza
S
S
Cirak
A
A
Glover
M
M
Guglieri
L
L
Feng
K G
KG
Hollingsworth
D
D
Hunt
H
H
Jungbluth
H P
HP
Roper
R M
RM
Quinlivan
J A
JA
Gosalakkal
S
S
Jayawant
A
A
Nadeau
L
L
Hughes-Carre
A Y
AY
Manzur
E
E
Mercuri
J E
JE
Morgan
V
V
Straub
K
K
Bushby
C
C
Sewry
M
M
Rutherford
F
F
Muntoni
D000293:Adolescent; D002648:Child; D005528:Foot; D006801:Humans; D007866:Leg; D008279:Magnetic Resonance Imaging; D008297:Male; D018482:Muscle, Skeletal / Q000473:pathology* / Q000503:physiopathology; D020388:Muscular Dystrophy, Duchenne / Q000473:pathology* / Q000503:physiopathology
Rinsho Shinkeigaku. 1989 Jan;29(1):23-9
2743685
N Engl J Med. 2007 Dec 27;357(26):2677-86
18160687
AJR Am J Roentgenol. 2008 Jan;190(1):W8-12
18094282
Neuromuscul Disord. 2006 Mar;16(3):210-9
16497502
Arch Neurol. 2009 Jan;66(1):32-8
19139297
Curr Opin Neurol. 2007 Oct;20(5):590-4
17885450
No To Hattatsu. 1991 Jan;23(1):39-43
1994993
Br J Radiol. 1990 Dec;63(756):946-50
2268764
Neuromuscul Disord. 1992;2(5-6):379-87
1300186
Neuromuscul Disord. 2008 Mar;18(3):268-75
18207401
Lancet. 1999 Feb 13;353(9152):557-8
10028989
Pediatr Radiol. 1987;17(6):495-7
3684364
Lancet Neurol. 2009 Oct;8(10):918-28
19713152
Eur J Paediatr Neurol. 2000;4(5):219-23
11030068
Radiology. 1993 Feb;186(2):475-80
8421754
Diabetes Care. 2004 Oct;27(10):2382-5
15451904
J Magn Reson Imaging. 2007 Feb;25(2):433-40
17260395
Diabetes Care. 2002 Aug;25(8):1444-50
12145248
AJR Am J Roentgenol. 1986 Mar;146(3):565-74
3484872
Eur J Paediatr Neurol. 2002;6(6):305-7
12401454
Neuromuscul Disord. 2007 Oct;17(9-10):719-20
17952895